News FeedDigital tools for recruiting and retaining people in randomised controlled trials: A systematic map of the evidence base just published media v4.jpg_SIA_JPG_fit_to_width_XL.jpg controlled trials (RCTs) are crucial sources of evidence to inform health policy and practice. However, RCTs routinely struggle to recruit and retain adequate numbers of people, meaning that their results are often delayed or the trials have to be abandoned altogether., 12 Jun 2020 00:00:00 +0100SHTAC to assess effectiveness of COVID-19 diagnostic tests and treatments to inform NICE guidance to the NHS news 480 x297.jpg_SIA_JPG_fit_to_width_XL.jpg responds to the challenges of the coronavirus pandemic., 08 Apr 2020 00:00:00 +0100Keep up to date with SHTAC news you know you can keep up to date with the SHTAC newsletter?, 25 Feb 2020 00:00:00 +0000NICE guidance informed by SHTAC report on Cemiplimab for treating metastatic or locally advanced cutaneous squamous cell carcinoma National Institute for Health and Care Excellence (NICE) has issued guidance to the National Health Service (NHS) on the use of Cemiplimab as an option for treating locally advanced or metastatic cutaneous squamous cell carcinoma in adult, informed by a report produced by SHTAC., 20 Feb 2020 00:00:00 +0000SHTAC begins work on a rapid review of the effectiveness of digital tools for recruitment and retention of participants in clinical trials graphic news.jpg_SIA_JPG_fit_to_width_XL.jpg and retaining participants in randomised controlled trials is challenging, with poor rates of recruitment commonly reported. This can have negative consequences, for example delaying the setting up and completing of trials, meaning that patients, health professionals and decision makers have to wait longer to find out if new health treatments are effective., 24 Jan 2020 00:00:00 +0000